Uric acid better marker of fatty liver disease than MetS in obese youth: Study

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2022-07-25 14:00 GMT | Update On 2022-07-25 14:00 GMT

Italy: High serum uric acid (HUA) is a useful marker of fatty liver disease (FLD) in overweight/obese youths, a recent study has concluded. This is due to the greater ability of HUA to identify those at increased risk of the disease compared to metabolic syndrome (MetS). The study appears in Diabetes/Metabolism Research and Reviews.

The study was conducted by Melania Manco, Children's Hospital Bambino Gesù, IRCCS, Rome, Italy, and colleagues with the objective to compare the association of high serum uric acid or metabolic syndrome with fatty liver disease in youths with overweight/obesity (OW/OB).

For this purpose, the researchers conducted a cross-sectional study of anthropometrics, biochemical variables, and liver ultrasound of 3104 patients with OW/OB aged 5-17 years. MetS were defined by ≥3 criteria 1) high waist circumference; 2) high triglycerides; 3) low high-density lipoproteins; 4) fasting glucose ≥100 mg/dL; 5) blood pressure ≥95th percentile in children, and ≥130/80 mmHg in adolescents. HUA was defined as serum UA value ≥ 75th percentile adjusted for sex. Echography was determined using FLD.

Based on the study, the researchers reported the following findings:

The sample was stratified into four categories: 1) no HUA, no MetS (reference category); 2) MetS; 3) HUA; 4) HUA and MetS (HUA+MetS).
The prevalence of FLD increased across the four categories from 29.9%, 44.0%, 52.2% to 67.1%, respectively.
The ORs for the categorical variables were 1.33 for MetS, 3.19 for HUA, and 3.72 for HUA+MetS, vs. the reference category regardless of the body mass index.

"Given its greater ability to identify those at increased risk of the disease compared to MetS, HUA represents a useful marker of FLD in youths with OW/OB," the researchers wrote. "There is a need to investigate the ability of both to predict incident FLD in a longitudinal study."

Reference:

Di Bonito, Procolo, et al. "Uric Acid Versus Metabolic Syndrome as Markers of Fatty Liver Disease in Young People With Overweight/obesity." Diabetes/metabolism Research and Reviews, 2022, pp. e3559.

Article Source : Diabetes/Metabolism Research and Reviews

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Medha Baranwal

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Uric acid better marker of fatty liver disease than MetS in obese youth: Study

Similar News

Medical Bulletin 05/Jul/2025

Investigational GLP-1 Receptor Agonist effective in Lowering HbA1c in Early Type 2 Diabetes: NEJM

Could Your Saliva Predict Diabetes Risk? Study Finds Out

Early Infections and Obesity in Boys May Reduce Key Male Hormone: Study Suggests

Can Lifestyle Changes Really Prevent Diabetes? Study Provides Insights

Renal Dysfunction Raises Risk of Vertebral Fractures in T2DM Patients, reveals study

Hypertensive Pregnancy Disorders Linked to Long-Term Cardiovascular Risk in Women with Type 1 Diabetes: Study

Medical Bulletin 04/Jul/2025